- Insurance leaders named to terrorism risk-sharing committee
Nine insurance executives have been appointed to the federal Advisory Committee on Risk-Sharing Mechanisms, the U.S. Treasury Department announced Wednesday.
- Comp favorable for deceased injured worker’s family despite drug test results
The family of a man who died after a work accident may be able to receive workers compensation death benefits even though the worker tested positive for marijuana, a Louisiana appellate court has ruled.
- Comment deadline on proposed OSHA injury reporting rule extended
The U.S. Occupational Safety and Health Administration has extended to Oct. 28 its public comment deadline on a proposed rule to clarify an employer’s continuing obligation to accurately record workplace injuries and illnesses.
- Swiss Re unit to buy private life and pension consolidator
Swiss Re Ltd. on Wednesday said its Admin Re unit will buy Guardian Holdings Europe Ltd., the holding company for Guardian Financial Services, from London-based private equity firm Cinven for £1.6 billion ($2.49 billion).
- Hillary Clinton's prescription drug plan not what the doctor ordered
Democratic presidential candidate Hillary Clinton’s plan to curb rising prescription drug costs does little to lower costs, and instead could harm innovation and lead to hikes in insurance premiums, experts say.
- Bayer unit pays $5.6 million to settle chemical accident charges
Bayer CropScience A.G. will pay $5.6 million to resolve violations related to an explosion that killed two employees in 2008, federal regulators announced.
- Contraceptive mandate heading to Supreme Court?
Religious nonprofit groups seeking to be exempted from the health care reform law’s contraceptive mandate are closer to having their arguments heard by the U.S. Supreme Court following two appeals court rulings.
- Business interruption cover protects life sciences companies
Marsh L.L.C. said Wednesday that it has joined with Munich Reinsurance Co. to launch NDBI Pharma IQ, a nondamage business interruption insurance solution for life sciences companies.
- Volkswagen boss quits; insurance unlikely to respond to scandal
(Reuters) — Volkswagen A.G. CEO Martin Winterkorn resigned on Wednesday, taking responsibility for the German carmaker’s rigging of U.S. emissions tests in the biggest scandal in its 78-year history.